Pharmaceutical markets increase need for new water & wastewater treatment technologies

North American pharmaceutical water, wastewater, turnkey solutions, and operations & maintenance markets look set for growth as pharmaceutical drug manufacturing practices increase need for effective water and wastewater treatment technologies and services. Current and emerging technologies and services must continue to meet regulatory demands and prepare for upcoming demands caused by ever-changing manufacturing processes. Partnerships with key drug manufacturers will enhance effective design, development and implementation of future technologies and services to address growing needs of the industry.

New analysis from Frost & Sullivan, North American Pharmaceutical Water, Wastewater, Turnkey Solutions, and Operations & Maintenance Markets, finds that the market earned revenues of $344.9 million in 2006 and estimates this to reach $488.3 in 2013.

'The size of the North American pharmaceutical drug manufacturing industry is the driving force behind the advancement and growth of emerging treatment equipment, technologies and services,' notes Frost & Sullivan Research Analyst Eric Meliton. 'Regulatory compliance issues and the volume of water required and wastewater produced by this manufacturing segment will continue to drive industry growth.'

Providing compliant, manufacture-grade water and addressing large volumes of wastewater discharge are key concerns for the North American pharmaceutical drug manufacturing industry. Treatment equipment technologies and relevant services are pivotal to improve regulatory compliance and reduce operating costs. Companies who can properly address these issues can excel in the North American marketplace.

Effective water and wastewater treatment technologies that address operational requirements and ensure compliance with various water and wastewater standards require large investments in design, development and implementation. The ability to offer turnkey solutions and compliant operations & maintenance services that address the various needs of drug manufacturers is an additional challenge.

'With competition levels likely to increase through 2013, it is important for key vendors and service providers to create partnerships with North American Tier I and Tier II pharmaceutical drug manufacturers,' says Meliton. 'For current and emerging companies in this industry, products and services must be designed and implemented to address the regulatory standard requirements, while keeping operating costs affordable in the future.'

Moving forward, participants in the North American pharmaceutical water, wastewater, turnkey solutions, and operations & maintenance markets must anticipate dynamic regulatory requirements and demands of the pharmaceutical drug manufacturing industry to properly address treatment demands. A unique and beneficial partnership can be created by the enticement of drug manufacturers to work hands-on in design, development and implementation stages of treatment technologies.

North American Pharmaceutical Water, Wastewater, Turnkey Solutions, and Operations & Maintenance Markets is part of the Environmental Growth Partnership Service program, which also includes research in the following markets: Strategic Assessment of Water and Wastewater Treatment Requirements for the Canadian Oil Sands Markets, United States Water and Wastewater Treatment Opportunities Analysis – Southwest Regional Analysis and North American Markets for Water Treatment in the Power Industry. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants. Interviews with the press are available.